Exicure, Inc.
(NASDAQ : XCUR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
REGNRegeneron Pharmaceuticals, Inc. -1.13%723.622.6%$746.21m
AMGNAmgen, Inc. -0.20%230.481.4%$607.29m
BIIBBiogen, Inc. -0.66%260.541.8%$576.24m
MRNAModerna, Inc. -3.62%120.630.0%$568.63m
GILDGilead Sciences, Inc. -0.63%64.541.0%$546.58m
VRTXVertex Pharmaceuticals, Inc. -0.34%297.631.9%$428.48m
ILMNIllumina, Inc. -2.04%208.383.2%$402.46m
SNSSSunesis Pharmaceuticals, Inc. 0.75%4.050.7%$283.11m
SAVACassava Sciences, Inc. -4.97%40.250.0%$180.27m
BNTXBioNTech SE -0.77%136.470.0%$108.56m
TECHBio-Techne Corp. -4.42%295.434.5%$96.32m
BMRNBioMarin Pharmaceutical, Inc. -3.64%88.154.2%$92.43m
PRTAProthena Corp. Plc -2.17%57.3013.8%$77.50m
CRSPCRISPR Therapeutics AG -3.92%62.700.6%$75.15m
NVAXNovavax, Inc. -8.35%16.5775.6%$72.85m

Company Profile

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. Its product pipeline include Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Skokie, IL.